Inadequate imipenem dosing in patients with decreased kidney function: a global clinical pharmacokinetic study
Clinical Microbiology and Infection · 2025
DOI: 10.1016/j.cmi.2025.05.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2025. Verfasst von Anh Quan Truong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands; Rotterdam Clinical Pharmacometrics Group, Rotterdam, …. Hauptthemen laut MEDLINE: Imipenem, Anti-Bacterial Agents, Pseudomonas Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Geneva University Hospitals.
Abstract (Originalsprache)
OBJECTIVES: A number of population pharmacokinetic (popPK) models of imipenem in critically ill patients are available for dosing optimization, but they represent only a narrow range of kidney functions. This study evaluates the target attainment of on-label regimens through popPK modelling and simulation in patients across different kidney functions. METHODS: A popPK model was built based on two datasets from Switzerland (model development population, 151 patients, 322 concentrations) and externally validated on two datasets from the Czech Republic (19 patients, 111 concentrations) and Vietnam (43 patients, 85 concentrations). Monte Carlo simulations were performed to evaluate the probability of target attainment from a MIC of 0.125 mg/L to 32 mg/L. We estimated the cumulative fraction of response against Pseudomonas aeruginosa (the epidemiological cut-off value was 4 mg/L) across a broad range of Cockcroft-Gault creatinine clearance values (CLCRCG 15-130 mL/min). Targets of 40% and 100%ƒT > MIC (percentage of dosing interval estimated free concentrations above MIC) were investigated. RESULTS: Decreased kidney function estimated glomerular filtration rate by the Chronic Kidney Disease Epidemiology Collaboration 2021 (eGFRCKD-EPI MIC2mg/L. With a 100%ƒT > MIC target, 500 mg q6h (CLCRCG 30-60 mL/min) could only cover an MIC of up to 1 mg/L, irrespective of infusion time. For cumulative fraction of response, no dosing regimen could cover susceptible P. aeruginosa for 100%ƒT > MIC. DISCUSSION: The highest on-label imipenem dosing regimens failed to attain 100% ƒT > MIC4mg/L in patients with decreased kidney function. Higher dosing may be necessary to cover MIC of 4 mg/L. Future trials should explore their efficacy, toxicity, and the utility of model-informed precision dosing in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands; National Drug Information and Adverse Drug Reaction M…
- Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands.
- Division of General Internal Medicine, Geneva University Hospitals, Geneva, Switzerland; Clinical Pharmacology and Toxicology Service, Anesthesiology Pharmacology and Intensive Care Department, Geneva University Hospita…
- Intensive Care Unit, Bach Mai Hospital, Hanoi, Vietnam.
- 2nd Faculty of Medicine, Charles University in Prague, Czech Republic.
- Division of Infectious Diseases, Geneva University Hospitals, Faculty of Medicine, Geneva, Switzerland.
Förderung
- Geneva University Hospitals
Zitieren
APA
Truong, A. Q., Smeets, T. J. L., Terrier, J., Li, L., Dao, X. C., Strojil, J., Preijers, T., Koch, B. C. P., Huttner, A., & Sassen, S. D. T. (2025). Inadequate imipenem dosing in patients with decreased kidney function: a global clinical pharmacokinetic study. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2025.05.005
Vancouver
Truong AQ, Smeets TJL, Terrier J, Li L, Dao XC, Strojil J, et al. Inadequate imipenem dosing in patients with decreased kidney function: a global clinical pharmacokinetic study. Clinical Microbiology and Infection. 2025. doi:10.1016/j.cmi.2025.05.005
BibTeX
@article{Truong2025,
author = {Truong, Anh Quan and Smeets, Tim J L and Terrier, Jean and Li, Letao and Dao, Xuan Co and Strojil, Jan and Preijers, Tim and Koch, Birgit C P and Huttner, Angela and Sassen, Sebastiaan D T},
title = {Inadequate imipenem dosing in patients with decreased kidney function: a global clinical pharmacokinetic study},
journal = {Clinical Microbiology and Infection},
year = {2025},
doi = {10.1016/j.cmi.2025.05.005}
}
EUVIMED